Literature DB >> 22884876

Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells.

Glyn Chidlow1, John P M Wood, Andreas Ebneter, Robert J Casson.   

Abstract

It is increasingly recognised that chronically activated glia contribute to the pathology of various neurodegenerative diseases, including glaucoma. One means by which this can occur is through the release of neurotoxic, proinflammatory factors. In the current study, we therefore investigated the spatio-temporal patterns of expression of three such cytokines, IL-1β, TNFα and IL-6, in a validated rat model of experimental glaucoma. First, only weak evidence was found for increased expression of IL-1β and TNFα following induction of ocular hypertension. Second, and much more striking, was that robust evidence was uncovered showing IL-6 to be synthesised by injured retinal ganglion cells following elevation of intraocular pressure and transported in an orthograde fashion along the nerve, accumulating at sites of axonal disruption in the optic nerve head. Verification that IL-6 represents a novel marker of disrupted axonal transport in this model was obtained by performing double labelling immunofluorescence with recognised markers of fast axonal transport. The stimulus for IL-6 synthesis and axonal transport during experimental glaucoma arose from axonal injury rather than ocular hypertension, as the response was identical after optic nerve crush and bilateral occlusion of the carotid arteries, each of which is independent of elevated intraocular pressure. Moreover, the response of IL-6 was not a generalised feature of the gp130 family of cytokines, as it was not mimicked by another family member, ciliary neurotrophic factor. Finally, further study suggested that IL-6 may be an early part of the endogenous regenerative response as the cytokine colocalised with growth-associated membrane phosphoprotein-43 in some putative regenerating axons, and potently stimulated neuritogenesis in retinal ganglion cells in culture, an effect that was additive to that of ciliary neurotrophic factor. These data comprise clear evidence that IL-6 is actively involved in the attempt of injured retinal ganglion cells to regenerate their axons.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884876     DOI: 10.1016/j.nbd.2012.07.026

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  27 in total

Review 1.  Molecular imaging of retinal disease.

Authors:  Megan E Capozzi; Andrew Y Gordon; John S Penn; Ashwath Jayagopal
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

2.  MCT2 overexpression rescues metabolic vulnerability and protects retinal ganglion cells in two models of glaucoma.

Authors:  Mohammad Harun-Or-Rashid; Nathaniel Pappenhagen; Ryan Zubricky; Lucy Coughlin; Assraa Hassan Jassim; Denise M Inman
Journal:  Neurobiol Dis       Date:  2020-05-15       Impact factor: 5.996

Review 3.  Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review.

Authors:  Bengi Ece Kurtul; Pinar Altiaylik Ozer
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

4.  The P2X7 receptor links mechanical strain to cytokine IL-6 up-regulation and release in neurons and astrocytes.

Authors:  Wennan Lu; Farraj Albalawi; Jonathan M Beckel; Jason C Lim; Alan M Laties; Claire H Mitchell
Journal:  J Neurochem       Date:  2017-05       Impact factor: 5.372

5.  Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury.

Authors:  Kimberly A Fernandes; Katherine L Mitchell; Amit Patel; Olivia J Marola; Peter Shrager; Donald J Zack; Richard T Libby; Derek S Welsbie
Journal:  Exp Eye Res       Date:  2018-03-08       Impact factor: 3.467

6.  Fisetin rescues retinal functions by suppressing inflammatory response in a DBA/2J mouse model of glaucoma.

Authors:  Linlin Li; Jie Qin; Tingting Fu; Jiaxiang Shen
Journal:  Doc Ophthalmol       Date:  2019-02-11       Impact factor: 2.379

Review 7.  The role of microglia in the progression of glaucomatous neurodegeneration- a review.

Authors:  Hui-Lan Zeng; Jing-Ming Shi
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

8.  Stressor-dependent Alterations in Glycoprotein 130: Implications for Glial Cell Reactivity, Cytokine Signaling and Ganglion Cell Health in Glaucoma.

Authors:  Fd Echevarria; Cc Walker; Sk Abella; M Won; Rm Sappington
Journal:  J Clin Exp Ophthalmol       Date:  2013-06-30

9.  Retina-on-a-chip: a microfluidic platform for point access signaling studies.

Authors:  Kirsten H Dodson; Franklin D Echevarria; Deyu Li; Rebecca M Sappington; Jon F Edd
Journal:  Biomed Microdevices       Date:  2015-12       Impact factor: 2.838

10.  Retinal Molecular Changes Are Associated with Neuroinflammation and Loss of RGCs in an Experimental Model of Glaucoma.

Authors:  José A Fernández-Albarral; Juan J Salazar; Rosa de Hoz; Eva M Marco; Beatriz Martín-Sánchez; Elena Flores-Salguero; Elena Salobrar-García; Inés López-Cuenca; Vicente Barrios-Sabador; Marcelino Avilés-Trigueros; Francisco J Valiente-Soriano; Juan A Miralles de Imperial-Ollero; Manuel Vidal-Sanz; Alberto Triviño; José M Ramírez; Meritxell López-Gallardo; Ana I Ramírez
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.